List of works by Elisa Caiola

Across the universe of K-RAS mutations in non-small-cell-lung cancer.

scientific article published on January 2014

Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX

scientific article published on October 2016

Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.

scientific article published on 2 September 2015

Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells.

scientific article

Co-occurring KRAS mutation/LKB1 loss in non-small cell lung cancer cells results in enhanced metabolic activity susceptible to caloric restriction: an in vitro integrated multilevel approach

scientific article published on 04 December 2018

Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo.

scientific article published on 22 June 2016

DNA repair gene polymorphisms in non-small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.

scientific article published on 7 July 2016

DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer

scientific article published on 13 December 2011

Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS.

scientific article published on 6 June 2016

Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells

scientific article

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial

scientific article published on 19 December 2018

G48A, a New KRAS Mutation Found in Lung Adenocarcinoma.

scientific article published on 4 April 2016

Genetic markers for prediction of treatment outcomes in ovarian cancer.

scientific article published on 08 July 2014

It's Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?

scientific article published on 01 November 2020

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

scientific article published on 15 September 2015

KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer.

scientific article published on 21 April 2012

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC

scientific article published on 24 August 2018

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)

scientific article

The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs

scientific article published on 14 December 2016

Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.

scientific article published on 17 January 2018

∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299.

scientific article published on 4 September 2015

Paulina is supported by:

About Paulina

Help